Lenacapavir Injection Market Size, Share, Trends, Growth 2034

Lenacapavir Injection Market

Lenacapavir Injection Market By Type (Single-Dose Pre-Filled Syringes, Multi-Dose Vials, Long Acting Injectable Formulations, Combination Injectable Formulations), By Application (HIV Pre-Exposure Prophylaxis, HIV Treatment Therapy, Post-Exposure Preventive Care, Clinical Research Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies), By End User (Hospitals and Clinics, Government Health Programs, Non-Profit Health Organizations, Individual Patients), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2026 - 2034

Category: Healthcare Report Format : PDF Pages: 227 Report Code: ZMR-10805 Published Date: Oct-2026 Status : Published
Market Size in 2025 Market Forecast in 2034 CAGR (in %) Base Year
USD 3.66 Billion USD 5.68 Billion 4.99% 2025

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Lenacapavir Injection Market, (2026 - 2034) (USD Billion)
    • 2.2 Global Lenacapavir Injection Market : snapshot
  • Chapter 3. Global Lenacapavir Injection Market - Industry Analysis
    • 3.1 Lenacapavir Injection Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Expanding government funding is creating new opportunities in the lenacapavir injection market.
    • 3.3 Market Restraints
      • 3.3.1. Affordability and access barriers affecting the lenacapavir injection market
    • 3.4 Market Opportunities
      • 3.4.1. Health partnerships create new opportunities in the lenacapavir injection market
    • 3.5 Market Challenges
      • 3.5.1. Manufacturing and distribution limitations are creating challenges for the lenacapavir injection market.
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Type
      • 3.7.2 Market attractiveness analysis By Application
      • 3.7.3 Market attractiveness analysis By Distribution Channel
      • 3.7.4 Market attractiveness analysis By End User
  • Chapter 4. Global Lenacapavir Injection Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Lenacapavir Injection Market: company market share, 2025
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Lenacapavir Injection Market - Type Analysis
    • 5.1 Global Lenacapavir Injection Market overview: By Type
      • 5.1.1 Global Lenacapavir Injection Market share, By Type, 2025 and 2034
    • 5.2 Single Dose Pre-Filled Syringes
      • 5.2.1 Global Lenacapavir Injection Market by Single Dose Pre-Filled Syringes, 2026 - 2034 (USD Billion)
    • 5.3 Multi-Dose Vials
      • 5.3.1 Global Lenacapavir Injection Market by Multi-Dose Vials, 2026 - 2034 (USD Billion)
    • 5.4 Long-Acting Injectable Formulations
      • 5.4.1 Global Lenacapavir Injection Market by Long-Acting Injectable Formulations, 2026 - 2034 (USD Billion)
    • 5.5 Combination Injectable Formulations
      • 5.5.1 Global Lenacapavir Injection Market by Combination Injectable Formulations, 2026 - 2034 (USD Billion)
  • Chapter 6. Global Lenacapavir Injection Market - Application Analysis
    • 6.1 Global Lenacapavir Injection Market overview: By Application
      • 6.1.1 Global Lenacapavir Injection Market share, By Application, 2025 and 2034
    • 6.2 HIV Pre-Exposure Prophylaxis
      • 6.2.1 Global Lenacapavir Injection Market by HIV Pre-Exposure Prophylaxis, 2026 - 2034 (USD Billion)
    • 6.3 HIV Treatment Therapy
      • 6.3.1 Global Lenacapavir Injection Market by HIV Treatment Therapy, 2026 - 2034 (USD Billion)
    • 6.4 Post-Exposure Preventive Care
      • 6.4.1 Global Lenacapavir Injection Market by Post-Exposure Preventive Care, 2026 - 2034 (USD Billion)
    • 6.5 Clinical Research Applications
      • 6.5.1 Global Lenacapavir Injection Market by Clinical Research Applications, 2026 - 2034 (USD Billion)
  • Chapter 7. Global Lenacapavir Injection Market - Distribution Channel Analysis
    • 7.1 Global Lenacapavir Injection Market overview: By Distribution Channel
      • 7.1.1 Global Lenacapavir Injection Market share, By Distribution Channel, 2025 and 2034
    • 7.2 Hospital Pharmacies
      • 7.2.1 Global Lenacapavir Injection Market by Hospital Pharmacies, 2026 - 2034 (USD Billion)
    • 7.3 Retail Pharmacies
      • 7.3.1 Global Lenacapavir Injection Market by Retail Pharmacies, 2026 - 2034 (USD Billion)
    • 7.4 Specialty Clinics
      • 7.4.1 Global Lenacapavir Injection Market by Specialty Clinics, 2026 - 2034 (USD Billion)
    • 7.5 Online Pharmacies
      • 7.5.1 Global Lenacapavir Injection Market by Online Pharmacies, 2026 - 2034 (USD Billion)
  • Chapter 8. Global Lenacapavir Injection Market - End User Analysis
    • 8.1 Global Lenacapavir Injection Market overview: By End User
      • 8.1.1 Global Lenacapavir Injection Market share, By End User, 2025 and 2034
    • 8.2 Hospitals and Clinics
      • 8.2.1 Global Lenacapavir Injection Market by Hospitals and Clinics, 2026 - 2034 (USD Billion)
    • 8.3 Government Health Programs
      • 8.3.1 Global Lenacapavir Injection Market by Government Health Programs, 2026 - 2034 (USD Billion)
    • 8.4 Non-profit Health Organizations
      • 8.4.1 Global Lenacapavir Injection Market by Non-profit Health Organizations, 2026 - 2034 (USD Billion)
    • 8.5 Individual Patients
      • 8.5.1 Global Lenacapavir Injection Market by Individual Patients, 2026 - 2034 (USD Billion)
  • Chapter 9. Lenacapavir Injection Market - Regional Analysis
    • 9.1 Global Lenacapavir Injection Market Regional Overview
    • 9.2 Global Lenacapavir Injection Market Share, by Region, 2025 & 2034 (USD Billion)
    • 9.3. North America
      • 9.3.1 North America Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
        • 9.3.1.1 North America Lenacapavir Injection Market, by Country, 2026 - 2034 (USD Billion)
    • 9.4 North America Lenacapavir Injection Market, by Type, 2026 - 2034
      • 9.4.1 North America Lenacapavir Injection Market, by Type, 2026 - 2034 (USD Billion)
    • 9.5 North America Lenacapavir Injection Market, by Application, 2026 - 2034
      • 9.5.1 North America Lenacapavir Injection Market, by Application, 2026 - 2034 (USD Billion)
    • 9.6 North America Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034
      • 9.6.1 North America Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034 (USD Billion)
    • 9.7 North America Lenacapavir Injection Market, by End User, 2026 - 2034
      • 9.7.1 North America Lenacapavir Injection Market, by End User, 2026 - 2034 (USD Billion)
    • 9.4. Europe
      • 9.4.2 Europe Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
        • 9.4.2.1 Europe Lenacapavir Injection Market, by Country, 2026 - 2034 (USD Billion)
    • 9.4 Europe Lenacapavir Injection Market, by Type, 2026 - 2034
      • 9.4.1 Europe Lenacapavir Injection Market, by Type, 2026 - 2034 (USD Billion)
    • 9.5 Europe Lenacapavir Injection Market, by Application, 2026 - 2034
      • 9.5.1 Europe Lenacapavir Injection Market, by Application, 2026 - 2034 (USD Billion)
    • 9.6 Europe Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034
      • 9.6.1 Europe Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034 (USD Billion)
    • 9.7 Europe Lenacapavir Injection Market, by End User, 2026 - 2034
      • 9.7.1 Europe Lenacapavir Injection Market, by End User, 2026 - 2034 (USD Billion)
    • 9.5. Asia Pacific
      • 9.5.3 Asia Pacific Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
        • 9.5.3.1 Asia Pacific Lenacapavir Injection Market, by Country, 2026 - 2034 (USD Billion)
    • 9.4 Asia Pacific Lenacapavir Injection Market, by Type, 2026 - 2034
      • 9.4.1 Asia Pacific Lenacapavir Injection Market, by Type, 2026 - 2034 (USD Billion)
    • 9.5 Asia Pacific Lenacapavir Injection Market, by Application, 2026 - 2034
      • 9.5.1 Asia Pacific Lenacapavir Injection Market, by Application, 2026 - 2034 (USD Billion)
    • 9.6 Asia Pacific Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034
      • 9.6.1 Asia Pacific Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034 (USD Billion)
    • 9.7 Asia Pacific Lenacapavir Injection Market, by End User, 2026 - 2034
      • 9.7.1 Asia Pacific Lenacapavir Injection Market, by End User, 2026 - 2034 (USD Billion)
    • 9.6. Latin America
      • 9.6.4 Latin America Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
        • 9.6.4.1 Latin America Lenacapavir Injection Market, by Country, 2026 - 2034 (USD Billion)
    • 9.4 Latin America Lenacapavir Injection Market, by Type, 2026 - 2034
      • 9.4.1 Latin America Lenacapavir Injection Market, by Type, 2026 - 2034 (USD Billion)
    • 9.5 Latin America Lenacapavir Injection Market, by Application, 2026 - 2034
      • 9.5.1 Latin America Lenacapavir Injection Market, by Application, 2026 - 2034 (USD Billion)
    • 9.6 Latin America Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034
      • 9.6.1 Latin America Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034 (USD Billion)
    • 9.7 Latin America Lenacapavir Injection Market, by End User, 2026 - 2034
      • 9.7.1 Latin America Lenacapavir Injection Market, by End User, 2026 - 2034 (USD Billion)
    • 9.7. The Middle-East and Africa
      • 9.7.5 The Middle-East and Africa Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
        • 9.7.5.1 The Middle-East and Africa Lenacapavir Injection Market, by Country, 2026 - 2034 (USD Billion)
    • 9.4 The Middle-East and Africa Lenacapavir Injection Market, by Type, 2026 - 2034
      • 9.4.1 The Middle-East and Africa Lenacapavir Injection Market, by Type, 2026 - 2034 (USD Billion)
    • 9.5 The Middle-East and Africa Lenacapavir Injection Market, by Application, 2026 - 2034
      • 9.5.1 The Middle-East and Africa Lenacapavir Injection Market, by Application, 2026 - 2034 (USD Billion)
    • 9.6 The Middle-East and Africa Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034
      • 9.6.1 The Middle-East and Africa Lenacapavir Injection Market, by Distribution Channel, 2026 - 2034 (USD Billion)
    • 9.7 The Middle-East and Africa Lenacapavir Injection Market, by End User, 2026 - 2034
      • 9.7.1 The Middle-East and Africa Lenacapavir Injection Market, by End User, 2026 - 2034 (USD Billion)
  • Chapter 10. Company Profiles
    • 10.1 Gilead Sciences
      • 10.1.1 Overview
      • 10.1.2 Financials
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 ViiV Healthcare
      • 10.2.1 Overview
      • 10.2.2 Financials
      • 10.2.3 Product Portfolio
      • 10.2.4 Business Strategy
      • 10.2.5 Recent Developments
    • 10.3 Merck and Co
      • 10.3.1 Overview
      • 10.3.2 Financials
      • 10.3.3 Product Portfolio
      • 10.3.4 Business Strategy
      • 10.3.5 Recent Developments
    • 10.4 Johnson and Johnson
      • 10.4.1 Overview
      • 10.4.2 Financials
      • 10.4.3 Product Portfolio
      • 10.4.4 Business Strategy
      • 10.4.5 Recent Developments
    • 10.5 Mylan Pharmaceuticals
      • 10.5.1 Overview
      • 10.5.2 Financials
      • 10.5.3 Product Portfolio
      • 10.5.4 Business Strategy
      • 10.5.5 Recent Developments
    • 10.6 Cipla Limited
      • 10.6.1 Overview
      • 10.6.2 Financials
      • 10.6.3 Product Portfolio
      • 10.6.4 Business Strategy
      • 10.6.5 Recent Developments
    • 10.7 Aurobindo Pharma
      • 10.7.1 Overview
      • 10.7.2 Financials
      • 10.7.3 Product Portfolio
      • 10.7.4 Business Strategy
      • 10.7.5 Recent Developments
    • 10.8 Hetero Drugs
      • 10.8.1 Overview
      • 10.8.2 Financials
      • 10.8.3 Product Portfolio
      • 10.8.4 Business Strategy
      • 10.8.5 Recent Developments
    • 10.9 Mankind Pharma
      • 10.9.1 Overview
      • 10.9.2 Financials
      • 10.9.3 Product Portfolio
      • 10.9.4 Business Strategy
      • 10.9.5 Recent Developments
    • 10.10 Sun Pharmaceutical Industries
      • 10.10.1 Overview
      • 10.10.2 Financials
      • 10.10.3 Product Portfolio
      • 10.10.4 Business Strategy
      • 10.10.5 Recent Developments
    • 10.11 and others.
      • 10.11.1 Overview
      • 10.11.2 Financials
      • 10.11.3 Product Portfolio
      • 10.11.4 Business Strategy
      • 10.11.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Lenacapavir Injection Market attractiveness, By Type
  • 6. Global Lenacapavir Injection Market attractiveness, By Application
  • 7. Global Lenacapavir Injection Market attractiveness, By Distribution Channel
  • 8. Global Lenacapavir Injection Market attractiveness, By End User
  • 9. Global Lenacapavir Injection Market share by Type, 2026 and 2034 (USD Billion)
  • 10. Global Lenacapavir Injection Market by Single Dose Pre-Filled Syringes, 2026 - 2034 (USD Billion)
  • 11. Global Lenacapavir Injection Market by Multi-Dose Vials, 2026 - 2034 (USD Billion)
  • 12. Global Lenacapavir Injection Market by Long-Acting Injectable Formulations, 2026 - 2034 (USD Billion)
  • 13. Global Lenacapavir Injection Market by Combination Injectable Formulations, 2026 - 2034 (USD Billion)
  • 14. Global Lenacapavir Injection Market share by Application, 2026 and 2034 (USD Billion)
  • 15. Global Lenacapavir Injection Market by HIV Pre-Exposure Prophylaxis, 2026 - 2034 (USD Billion)
  • 16. Global Lenacapavir Injection Market by HIV Treatment Therapy, 2026 - 2034 (USD Billion)
  • 17. Global Lenacapavir Injection Market by Post-Exposure Preventive Care, 2026 - 2034 (USD Billion)
  • 18. Global Lenacapavir Injection Market by Clinical Research Applications, 2026 - 2034 (USD Billion)
  • 19. Global Lenacapavir Injection Market share by Distribution Channel, 2026 and 2034 (USD Billion)
  • 20. Global Lenacapavir Injection Market by Hospital Pharmacies, 2026 - 2034 (USD Billion)
  • 21. Global Lenacapavir Injection Market by Retail Pharmacies, 2026 - 2034 (USD Billion)
  • 22. Global Lenacapavir Injection Market by Specialty Clinics, 2026 - 2034 (USD Billion)
  • 23. Global Lenacapavir Injection Market by Online Pharmacies, 2026 - 2034 (USD Billion)
  • 24. Global Lenacapavir Injection Market share by End User, 2026 and 2034 (USD Billion)
  • 25. Global Lenacapavir Injection Market by Hospitals and Clinics, 2026 - 2034 (USD Billion)
  • 26. Global Lenacapavir Injection Market by Government Health Programs, 2026 - 2034 (USD Billion)
  • 27. Global Lenacapavir Injection Market by Non-profit Health Organizations, 2026 - 2034 (USD Billion)
  • 28. Global Lenacapavir Injection Market by Individual Patients, 2026 - 2034 (USD Billion)
  • 29. Global Lenacapavir Injection Market share, by Region, 2026 and 2034
  • 30. North America Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
  • 31. Europe Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
  • 32. Asia Pacific Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
  • 33. Latin America Lenacapavir Injection Market, 2026 - 2034 (USD Billion)
  • 34. The Middle-East and Africa Lenacapavir Injection Market, 2026 - 2034 (USD Billion)

Table Of Tables

  • 1. Global Lenacapavir Injection Market: Snapshot
  • 2. Drivers of the Lenacapavir Injection Market: impact analysis
  • 3. North America Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 4. North America Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 5. North America Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 6. North America Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 7. U.S. Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 8. U.S. Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 9. U.S. Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 10. U.S. Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 11. Canada Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 12. Canada Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 13. Canada Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 14. Canada Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 15. Europe Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 16. Europe Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 17. Europe Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 18. Europe Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 19. Germany Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 20. Germany Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 21. Germany Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 22. Germany Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 23. France Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 24. France Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 25. France Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 26. France Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 27. U.K. Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 28. U.K. Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 29. U.K. Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 30. U.K. Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 31. Italy Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 32. Italy Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 33. Italy Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 34. Italy Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 35. Spain Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 36. Spain Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 37. Spain Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 38. Spain Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 39. Rest of Europe Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 40. Rest of Europe Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 41. Rest of Europe Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 42. Rest of Europe Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 43. Asia Pacific Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 44. Asia Pacific Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 45. Asia Pacific Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 46. Asia Pacific Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 47. China Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 48. China Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 49. China Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 50. China Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 51. Japan Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 52. Japan Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 53. Japan Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 54. Japan Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 55. India Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 56. India Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 57. India Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 58. India Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 59. South Korea Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 60. South Korea Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 61. South Korea Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 62. South Korea Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 63. South-East Asia Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 64. South-East Asia Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 65. South-East Asia Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 66. South-East Asia Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 67. Rest of Asia Pacific Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 68. Rest of Asia Pacific Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 69. Rest of Asia Pacific Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 70. Rest of Asia Pacific Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 71. Latin America Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 72. Latin America Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 73. Latin America Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 74. Latin America Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 75. Brazil Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 76. Brazil Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 77. Brazil Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 78. Brazil Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 79. Mexico Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 80. Mexico Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 81. Mexico Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 82. Mexico Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 83. Rest of Latin America Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 84. Rest of Latin America Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 85. Rest of Latin America Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 86. Rest of Latin America Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 87. The Middle-East and Africa Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 88. The Middle-East and Africa Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 89. The Middle-East and Africa Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 90. The Middle-East and Africa Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 91. GCC Countries Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 92. GCC Countries Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 93. GCC Countries Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 94. GCC Countries Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 95. South Africa Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 96. South Africa Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 97. South Africa Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 98. South Africa Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)
  • 99. Rest of Middle-East Africa Lenacapavir Injection Market revenue, By Type, 2026 - 2034 (USD Billion)
  • 100. Rest of Middle-East Africa Lenacapavir Injection Market revenue, By Application, 2026 - 2034 (USD Billion)
  • 101. Rest of Middle-East Africa Lenacapavir Injection Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
  • 102. Rest of Middle-East Africa Lenacapavir Injection Market revenue, By End User, 2026 - 2034 (USD Billion)

Methodology

FrequentlyAsked Questions

Lenacapavir injection is a long-acting HIV medicine given by injection to help prevent HIV infection and support treatment. Its extended dosing schedule reduces the need for frequent medication, helping people maintain their HIV prevention or treatment routine with greater convenience.

The global lenacapavir injection market is expected to grow due to rising HIV prevention initiatives, increasing preference for long-acting therapies, growing government health funding, and expanding access programs worldwide.

According to research, the global lenacapavir injection market was valued at approximately USD 3.66 billion in 2025 and is projected to reach approximately USD 5.68 billion by 2034.

The compound annual growth rate of the lenacapavir injection market is expected to be approximately 4.99% from 2026 to 2034.

North America is expected to lead the global lenacapavir injection market throughout the forecast period, driven by strong healthcare infrastructure, early regulatory approval, and well-established HIV prevention programs.

The major players in the global lenacapavir injection market include Gilead Sciences, ViiV Healthcare, Merck and Co, Johnson and Johnson, Mylan Pharmaceuticals, Cipla Limited, Aurobindo Pharma, Hetero Drugs, Mankind Pharma, and Sun Pharmaceutical Industries.

The report examines key aspects of the lenacapavir injection market, including growth drivers, adoption barriers, application opportunities, competitive landscape dynamics, detailed regional market performance analysis, and a comprehensive forward-looking outlook across all major types, applications, distribution channels, end-user segments, and geographic regions through 2034.

The lenacapavir injection market is seeing faster global rollout, wider use of twice-yearly HIV prevention, generic licensing, and stronger public health programs. New delivery models, expanded manufacturing partnerships, and broader use of long-acting prevention are improving product availability and helping healthcare systems reach more people at risk of HIV.

Technology is helping the lenacapavir injection market develop longer-lasting HIV medicines and simpler delivery options. Research into new formulations, including once-weekly oral lenacapavir, could give patients more choices for convenient HIV prevention.

HIV pre-exposure prophylaxis (PrEP) will offer major opportunities in the lenacapavir injection market, especially through national programs, community clinics, mobile healthcare, and services for people at higher risk of HIV. Growing demand for convenient, long-acting HIV prevention can further support adoption across underserved communities and high-burden regions.

  • zion payment modes

List of Contents

Lenacapavir InjectionIndustry Perspective:Key InsightsOverviewStrategic PerspectiveTechnology Roadmap 20262034DynamicsReport ScopeSegmentationRegional AnalysisRecent Market DevelopmentsCompetitive AnalysisThe global lenacapavir injection market is segmented as follows:

HappyClients